EZH2 and non-Hodgkin lymphoma: In nodal T-NHL cases, EZH1 (HR = 0.085; 95% CI: 0.008–0.859; p = 0.037; Table 3) and EZH2 (HR = 28.398; 95% CI: 2.166–372.334; p = 0.011; Table 3) were also independent prognostic markers for OS.